<PAGE> 1
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of
The Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): September 20, 2000
------------------
RENAL CARE GROUP, INC.
(Exact name of registrant as specified in its charter)
Delaware 0-27640 62-1622383
(State or other (Commission (IRS Employer
jurisdiction of File Number) Identification No.)
incorporation)
2100 West End Avenue, Suite 800, Nashville, Tennessee 37203
--------------------------------------------------------------------------------
(Address, including zip code, of principal executive offices)
(615) 345-5500
--------------------------------------------------------------------------------
(Registrant's telephone number, including area code)
<PAGE> 2
Item 5. Other Events.
On September 20, 2000, Renal Care Group, Inc. (the "Company") issued a
press release relating to the growth rate in the Company's earnings per share
over the next three to five years and the write-off of the Company's wound care
business. Such press release is attached hereto as Exhibit 99.1. On September
21, 2000 the Company held a conference call to discuss the press release. A copy
of the transcript of the conference call is attached hereto as Exhibit 99.2.
Item 7. Financial Statements and Exhibits.
(a) None.
(b) None.
(c) Exhibits.
99.1 Press Release issued September 20, 2000, regarding
the growth rate in the Company's earnings per share.
99.2 Transcript of conference call held at 8:00 a.m.,
Central Time, on September 21, 2000.
2
<PAGE> 3
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934,
the registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
RENAL CARE GROUP, INC.
By: /s/ R. Dirk Allison
----------------------------------------
Name: R. Dirk Allison
-------------------------------------
Title: Chief Financial Officer
-------------------------------------
Date: September 28, 2000
3
